Genflow Biosciences PLC (GENF)

Industry Biotechnology


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

1.65p

Buy

1.80p

arrow-up0.00p (+0.00%)

Prices updated at 12 Dec 2025, 15:39 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Sector
Healthcare
Industry
Biotechnology
Chairman
Ms. Tamara L. Joseph
CEO
Dr. Eric J. Leire
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
5
Head office
6 Heddon Street
London
United Kingdom
W1B 4BT
mobile
+44 2081425409
letter
info@genflowbio.com

Key personnel

Salary
Ms. Tamara L. Joseph
Non-Executive Director, Chairman
-
Dr. Yassine Bendiabdallah
Non-Executive Director
-
Dr. Peter King-Lewis
Non-Executive Director
-
Dr. Guy-Charles Fanneau de la Horie
Non-Executive Director
-
Dr. Eric J. Leire
Executive Director, Chief Executive Officer
-

Top 5 shareholders

No. of shares
Miton Asset Management Limited-
Premier Miton UK Smaller Companies-

Director dealings

Action
16 Oct 2025Purchase
15 May 2025Purchase
27 Mar 2025Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.